Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Epidemiology, molecular, and genetic methodologies to evaluate causes of CKDu around the world: report of the Working Group from the ISN International Consortium of Collaborators on CKDu.

Anand S, Caplin B, Gonzalez-Quiroz M, Schensul SL, Bhalla V, Parada X, Nanayakkara N, Fire A, Levin A, Friedman DJ; International Society of Nephrology’s International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology (i3C).

Kidney Int. 2019 Dec;96(6):1254-1260. doi: 10.1016/j.kint.2019.09.019. No abstract available.

PMID:
31759481
2.

Chronic kidney disease of undetermined aetiology: tens of thousands of premature deaths, yet too much remains unknown.

Mahalingasivam V, Caplin B.

Nephrol Dial Transplant. 2019 Nov 1;34(11):1839-1841. doi: 10.1093/ndt/gfz014. No abstract available.

PMID:
31681952
3.

Environmental exposures in young adults with declining kidney function in a population at risk of Mesoamerican nephropathy.

Smpokou ET, González-Quiroz M, Martins C, Alvito P, Le Blond J, Glaser J, Aragón A, Wesseling C, Nitsch D, Pearce N, Norman J, Lindh CH, Morton J, Caplin B.

Occup Environ Med. 2019 Dec;76(12):920-926. doi: 10.1136/oemed-2019-105772. Epub 2019 Sep 27.

PMID:
31562235
4.

Rationale and population-based prospective cohort protocol for the disadvantaged populations at risk of decline in eGFR (CO-DEGREE).

Gonzalez-Quiroz M, Nitsch D, Hamilton S, O'Callaghan Gordo C, Saran R, Glaser J, Correa-Rotter R, Jakobsson K, Singh A, Gunawardena N, Levin A, Remuzzi G, Caplin B, Pearce N; DEGREE Study Steering Committee.

BMJ Open. 2019 Sep 24;9(9):e031169. doi: 10.1136/bmjopen-2019-031169.

5.

The use of sirolimus in patients with recurrent cytomegalovirus infection after kidney transplantation: A retrospective case series analysis.

Shendi AM, Hung RKY, Caplin B, Griffiths P, Harber M.

Saudi J Kidney Dis Transpl. 2019 May-Jun;30(3):606-614. doi: 10.4103/1319-2442.261333.

PMID:
31249224
6.

Prevalence and risk factors for impaired kidney function in the district of Anuradhapura, Sri Lanka: a cross-sectional population-representative survey in those at risk of chronic kidney disease of unknown aetiology.

Ruwanpathirana T, Senanayake S, Gunawardana N, Munasinghe A, Ginige S, Gamage D, Amarasekara J, Lokuketagoda B, Chulasiri P, Amunugama S, Palihawadana P, Caplin B, Pearce N.

BMC Public Health. 2019 Jun 14;19(1):763. doi: 10.1186/s12889-019-7117-2.

7.

Let's take the heat out of the CKDu debate: more evidence is needed.

Pearce N, Caplin B.

Occup Environ Med. 2019 Jun;76(6):357-359. doi: 10.1136/oemed-2018-105427. Epub 2019 Mar 30. No abstract available.

8.

CKD of Unknown Cause: A Global Epidemic?

Pearce N, Caplin B, Gunawardena N, Kaur P, O'Callaghan-Gordo C, Ruwanpathirana T.

Kidney Int Rep. 2018 Dec 3;4(3):367-369. doi: 10.1016/j.ekir.2018.11.019. eCollection 2019 Mar. No abstract available.

9.

Prevalence of and risk factors for chronic kidney disease of unknown aetiology in India: secondary data analysis of three population-based cross-sectional studies.

O'Callaghan-Gordo C, Shivashankar R, Anand S, Ghosh S, Glaser J, Gupta R, Jakobsson K, Kondal D, Krishnan A, Mohan S, Mohan V, Nitsch D, P A P, Tandon N, Narayan KMV, Pearce N, Caplin B, Prabhakaran D.

BMJ Open. 2019 Mar 7;9(3):e023353. doi: 10.1136/bmjopen-2018-023353. Erratum in: BMJ Open. 2019 Mar 18;9(3):e023353corr1.

10.

Identification of young adults at risk of an accelerated loss of kidney function in an area affected by Mesoamerican nephropathy.

Gonzalez-Quiroz M, Smpokou ET, Pearce N, Caplin B, Nitsch D.

BMC Nephrol. 2019 Jan 16;20(1):21. doi: 10.1186/s12882-018-1193-x.

11.

The International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology: report of the working group on approaches to population-level detection strategies and recommendations for a minimum dataset.

Caplin B, Yang CW, Anand S, Levin A, Madero M, Saran R, Jayasinghe S, De Broe M, Yeates K, Tonelli M, Jakobsson K, Strani L, Ruggiero A, Glaser J, Martin E, Pearce N, Wijewickrama E; International Society of Nephrology’s International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology (i3C).

Kidney Int. 2019 Jan;95(1):4-10. doi: 10.1016/j.kint.2018.08.019. No abstract available. Erratum in: Kidney Int. 2019 Apr;95(4):997-998.

PMID:
30606428
12.

What do epidemiological studies tell us about chronic kidney disease of undetermined cause in Meso-America? A systematic review and meta-analysis.

González-Quiroz M, Pearce N, Caplin B, Nitsch D.

Clin Kidney J. 2018 Aug;11(4):496-506. doi: 10.1093/ckj/sfx136. Epub 2017 Dec 8.

13.

The National CKD Audit: a primary care condition that deserves more attention.

Hull SA, Nitsch D, Caplin B, Griffith K, Wheeler DC.

Br J Gen Pract. 2018 Aug;68(673):356-357. doi: 10.3399/bjgp18X697997. No abstract available.

14.

Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data.

Iwagami M, Caplin B, Smeeth L, Tomlinson LA, Nitsch D.

Br J Gen Pract. 2018 Aug;68(673):e512-e523. doi: 10.3399/bjgp18X697973. Epub 2018 Jul 16.

15.

Decline in Kidney Function among Apparently Healthy Young Adults at Risk of Mesoamerican Nephropathy.

Gonzalez-Quiroz M, Smpokou ET, Silverwood RJ, Camacho A, Faber D, Garcia BR, Oomatia A, Hill M, Glaser J, Le Blond J, Wesseling C, Aragon A, Smeeth L, Pearce N, Nitsch D, Caplin B.

J Am Soc Nephrol. 2018 Aug;29(8):2200-2212. doi: 10.1681/ASN.2018020151. Epub 2018 Jun 15.

16.

Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.

Brück K, Jager KJ, Zoccali C, Bello AK, Minutolo R, Ioannou K, Verbeke F, Völzke H, Arnlöv J, Leonardis D, Ferraro PM, Brenner H, Caplin B, Kalra PA, Wanner C, Castelao AM, Gorriz JL, Hallan S, Rothenbacher D, Gibertoni D, De Nicola L, Heinze G, Van Biesen W, Stel VS; European CKD Burden Consortium.

Kidney Int. 2018 Jun;93(6):1432-1441. doi: 10.1016/j.kint.2018.01.008. Epub 2018 Apr 12.

PMID:
29656901
17.

Chronic kidney disease-associated cardiovascular disease: scope and limitations of animal models.

Sadeghi-Alavijeh O, Tadayyon M, Caplin B.

Cardiovasc Endocrinol. 2017 Nov 15;6(4):120-127. doi: 10.1097/XCE.0000000000000132. eCollection 2017 Dec. Review.

18.

How do primary care doctors in England and Wales code and manage people with chronic kidney disease? Results from the National Chronic Kidney Disease Audit.

Kim LG, Cleary F, Wheeler DC, Caplin B, Nitsch D, Hull SA; UK National Chronic Kidney Disease Audit.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1373-1379. doi: 10.1093/ndt/gfx280.

19.

Accounting for overdispersion when determining primary care outliers for the identification of chronic kidney disease: learning from the National Chronic Kidney Disease Audit.

Kim LG, Caplin B, Cleary F, Hull SA, Griffith K, Wheeler DC, Nitsch D; UK National Chronic Kidney Disease Audit.

Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii151-ii158. doi: 10.1093/ndt/gfw398.

20.

Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1.

Gale DP, Molyneux K, Wimbury D, Higgins P, Levine AP, Caplin B, Ferlin A, Yin P, Nelson CP, Stanescu H, Samani NJ, Kleta R, Yu X, Barratt J.

J Am Soc Nephrol. 2017 Jul;28(7):2158-2166. doi: 10.1681/ASN.2016091043. Epub 2017 Feb 16.

21.

Rationale, description and baseline findings of a community-based prospective cohort study of kidney function amongst the young rural population of Northwest Nicaragua.

González-Quiroz M, Camacho A, Faber D, Aragón A, Wesseling C, Glaser J, Le Blond J, Smeeth L, Nitsch D, Pearce N, Caplin B.

BMC Nephrol. 2017 Jan 13;18(1):16. doi: 10.1186/s12882-016-0422-4.

22.

International Collaboration for the Epidemiology of eGFR in Low and Middle Income Populations - Rationale and core protocol for the Disadvantaged Populations eGFR Epidemiology Study (DEGREE).

Caplin B, Jakobsson K, Glaser J, Nitsch D, Jha V, Singh A, Correa-Rotter R, Pearce N.

BMC Nephrol. 2017 Jan 3;18(1):1. doi: 10.1186/s12882-016-0417-1.

23.

Urinary biomarkers of tubular injury in chronic kidney disease.

Caplin B, Nitsch D.

Kidney Int. 2017 Jan;91(1):21-23. doi: 10.1016/j.kint.2016.10.003.

24.

Infection Rates Following Buttonhole Cannulation in Hemodialysis Patients.

Collier S, Kandil H, Yewnetu E, Cross J, Caplin B, Davenport A.

Ther Apher Dial. 2016 Oct;20(5):476-482. doi: 10.1111/1744-9987.12409. Epub 2016 Mar 17.

PMID:
26991535
25.

Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Pepper RJ, Draibe JB, Caplin B, Fervenza FC, Hoffman GS, Kallenberg CG, Langford CA, Monach PA, Seo P, Spiera R, William St Clair E, Tchao NK, Stone JH, Specks U, Merkel PA, Salama AD; RAVE-Immune Tolerance Network Research Group.

Arthritis Rheumatol. 2017 Jan;69(1):185-193. doi: 10.1002/art.39814.

26.

Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis.

Lambden S, Kelly P, Ahmetaj-Shala B, Wang Z, Lee B, Nandi M, Torondel B, Delahaye M, Dowsett L, Piper S, Tomlinson J, Caplin B, Colman L, Boruc O, Slaviero A, Zhao L, Oliver E, Khadayate S, Singer M, Arrigoni F, Leiper J.

Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1382-92. doi: 10.1161/ATVBAHA.115.305278. Epub 2015 Apr 9.

PMID:
25857313
27.

Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.

Tomlinson JA, Caplin B, Boruc O, Bruce-Cobbold C, Cutillas P, Dormann D, Faull P, Grossman RC, Khadayate S, Mas VR, Nitsch DD, Wang Z, Norman JT, Wilcox CS, Wheeler DC, Leiper J.

J Am Soc Nephrol. 2015 Dec;26(12):3045-59. doi: 10.1681/ASN.2014030280. Epub 2015 Apr 8.

28.

Peritoneal protein clearance rather than faster transport status determines outcomes in peritoneal dialysis patients.

Rajakaruna G, Caplin B, Davenport A.

Perit Dial Int. 2015 Mar-Apr;35(2):216-21. doi: 10.3747/pdi.2013.00217. Epub 2014 Jul 31.

29.

Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors.

Tanna A, Guarino L, Tam FW, Rodriquez-Cubillo B, Levy JB, Cairns TD, Griffith M, Tarzi RM, Caplin B, Salama AD, Cook T, Pusey CD.

Nephrol Dial Transplant. 2015 Jul;30(7):1185-92. doi: 10.1093/ndt/gfu237. Epub 2014 Jul 12.

30.

Does online haemodiafiltration reduce intra-dialytic patient symptoms?

Caplin B, Alston H, Davenport A.

Nephron Clin Pract. 2013;124(3-4):184-90. doi: 10.1159/000357050. Epub 2014 Jan 4.

PMID:
24401696
31.

Early changes in scores of chronic damage on transplant kidney protocol biopsies reflect donor characteristics, but not future graft function.

Caplin B, Veighey K, Mahenderan A, Manook M, Henry J, Nitsch D, Harber M, Dupont P, Wheeler DC, Jones G, Fernando B, Howie AJ, Veitch P.

Clin Transplant. 2013 Nov-Dec;27(6):E669-78. doi: 10.1111/ctr.12251. Epub 2013 Oct 9.

32.

Alanine-glyoxylate aminotransferase-2 metabolizes endogenous methylarginines, regulates NO, and controls blood pressure.

Caplin B, Wang Z, Slaviero A, Tomlinson J, Dowsett L, Delahaye M, Salama A; International Consortium for Blood Pressure Genome-Wide Association Studies, Wheeler DC, Leiper J.

Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2892-900. doi: 10.1161/ATVBAHA.112.254078. Epub 2012 Sep 27.

PMID:
23023372
33.

New observational data demonstrate that mortality is lower in patients receiving more frequent dialysis.

Wheeler DC, Caplin B.

J Am Soc Nephrol. 2012 May;23(5):770-3. doi: 10.1681/ASN.2012030311. Epub 2012 Apr 12. No abstract available.

34.

Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?

Caplin B, Leiper J.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1343-53. doi: 10.1161/ATVBAHA.112.247726. Epub 2012 Mar 29. Review.

35.

Patients' perspective of haemodialysis-associated symptoms.

Caplin B, Kumar S, Davenport A.

Nephrol Dial Transplant. 2011 Aug;26(8):2656-63. doi: 10.1093/ndt/gfq763. Epub 2011 Jan 6.

PMID:
21212166
36.

Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms.

Caplin B, Nitsch D, Gill H, Hoefield R, Blackwell S, MacKenzie D, Cooper JA, Middleton RJ, Talmud PJ, Veitch P, Norman J, Wheeler DC, Leiper JM.

Kidney Int. 2010 Mar;77(5):459-67. doi: 10.1038/ki.2009.463. Epub 2009 Dec 9.

37.

Prospective monitoring of Epstein-Barr virus DNA in adult renal transplant recipients during the early posttransplant period: role of mycophenolate mofetil.

Holmes MV, Caplin B, Atkinson C, Smith C, Harber M, Sweny P, Haque T.

Transplantation. 2009 Mar 27;87(6):852-6. doi: 10.1097/TP.0b013e318199f983.

PMID:
19300188
38.
39.

Arterial calcification in dialysis patients and transplant recipients.

Caplin B, Wheeler DC.

Semin Dial. 2007 Mar-Apr;20(2):144-9. Review.

PMID:
17374089
40.

Antiviral treatment after solid organ transplantation.

Caplin B, Sweny P, Burroughs A, Emery V, Griffiths P.

Lancet. 2005 Sep 3-9;366(9488):806-7; author reply 807. No abstract available.

PMID:
16139651
42.

Mutational analysis of the beta-subunit of yeast geranylgeranyl transferase I.

Ohya Y, Caplin BE, Qadota H, Tibbetts MF, Anraku Y, Pringle JR, Marshall MS.

Mol Gen Genet. 1996 Aug 27;252(1-2):1-10.

43.

Mutagenesis and biochemical analysis of recombinant yeast prenyltransferases.

Caplin BE, Marshall MS.

Methods Enzymol. 1995;250:51-68.

PMID:
7651175
44.
45.

CDC43 and RAM2 encode the polypeptide subunits of a yeast type I protein geranylgeranyltransferase.

Mayer ML, Caplin BE, Marshall MS.

J Biol Chem. 1992 Oct 15;267(29):20589-93. Erratum in: J Biol Chem 1993 Feb 25;268(6):4568.

46.

Dinucleotide repeat polymorphism at the HOX 2B locus.

Dow E, Ferguson-Smith AC, Caplin B, Williamson R.

Hum Mol Genet. 1992 Jun;1(3):218. No abstract available.

PMID:
1363869

Supplemental Content

Loading ...
Support Center